BRPI0506753A - medicamento para a aplicação tópica em animais - Google Patents

medicamento para a aplicação tópica em animais

Info

Publication number
BRPI0506753A
BRPI0506753A BRPI0506753-7A BRPI0506753A BRPI0506753A BR PI0506753 A BRPI0506753 A BR PI0506753A BR PI0506753 A BRPI0506753 A BR PI0506753A BR PI0506753 A BRPI0506753 A BR PI0506753A
Authority
BR
Brazil
Prior art keywords
animals
topical application
medicine
absorbed
skin
Prior art date
Application number
BRPI0506753-7A
Other languages
English (en)
Inventor
Dirk Mertin
Gerald Beddies
Iris Heep
Nikolaus Kowollik
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of BRPI0506753A publication Critical patent/BRPI0506753A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

MEDICAMENTO PARA A APLICAçãO TóPICA EM ANIMAIS A presente invenção refere-se a preparações farmacêuticas, que são aplicadas no pêlo ou pele de animais e em seguida, essas são absorvidas pelos mesmos.
BRPI0506753-7A 2004-01-10 2005-01-07 medicamento para a aplicação tópica em animais BRPI0506753A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004001558A DE102004001558A1 (de) 2004-01-10 2004-01-10 Arzneimittel zur topischen Applikation bei Tieren
PCT/EP2005/000067 WO2005065713A2 (de) 2004-01-10 2005-01-07 Arzneimittel zur topischen applikation bei tieren

Publications (1)

Publication Number Publication Date
BRPI0506753A true BRPI0506753A (pt) 2007-05-22

Family

ID=34744661

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0506753-7A BRPI0506753A (pt) 2004-01-10 2005-01-07 medicamento para a aplicação tópica em animais

Country Status (11)

Country Link
US (1) US20080255125A1 (pt)
EP (1) EP1706097A2 (pt)
JP (1) JP5704738B2 (pt)
AU (1) AU2005203884B2 (pt)
BR (1) BRPI0506753A (pt)
CA (1) CA2552909C (pt)
DE (1) DE102004001558A1 (pt)
NO (1) NO20063626L (pt)
NZ (1) NZ548422A (pt)
WO (1) WO2005065713A2 (pt)
ZA (1) ZA200605611B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
DE102006010643A1 (de) * 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102006038292A1 (de) * 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
DE102007055341A1 (de) 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
DE102009012423A1 (de) * 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
CN103315986B (zh) * 2013-05-24 2014-09-03 湖北龙翔药业有限公司 一种可溶且稳定的帕托珠利组合物及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4402941A (en) * 1981-09-15 1983-09-06 Marc Vaillancourt Veterinary composition for preventing feline urological syndrome and litter product containing the composition
IN172468B (pt) * 1990-07-14 1993-08-14 Asta Medica Ag
US5122377A (en) * 1990-11-19 1992-06-16 A.H. Robins, Company, Incorporated Oral delivery system for veterinary drugs
NZ256788A (en) * 1992-09-30 1996-11-26 Cornell Res Foundation Inc Conferring resistance to fire blight in pomaceous fruit scion or cultivars through transformation with genes encoding lytic proteins
NZ332719A (en) * 1996-05-10 2000-01-28 Upjohn Co Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
US5929086A (en) * 1996-05-10 1999-07-27 Pharmacia & Upjohn Company Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
DE19824483A1 (de) * 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
WO2000019964A2 (en) * 1998-10-08 2000-04-13 New Ace Research Company Novel compositions and methods for prevention and treatment of protozoal disease
US6150361A (en) * 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
WO2000074714A2 (en) * 1999-06-03 2000-12-14 Glenn Gregory M Indicators for monitoring the technique of transcutaneous immunization
RU2002105502A (ru) * 1999-08-03 2004-03-20 АВД.фарма ГмбХ унд Ко. КГ (DE) Применение флупиртина для облегчения болей, вызванных дегенеративными заболеваниями суставов у собак и кошек
DE10040174A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE10224086A1 (de) * 2002-05-31 2003-12-11 Bayer Ag Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
DE10255415A1 (de) * 2002-11-28 2004-06-09 Bayer Healthcare Ag Dermale Applikation von Flupirtin
DE602004009664D1 (de) * 2003-01-16 2007-12-06 Janssen Pharmaceutica Nv Diclazurilhaltige antiprotozoenmittel

Also Published As

Publication number Publication date
JP2007519637A (ja) 2007-07-19
JP5704738B2 (ja) 2015-04-22
NO20063626L (no) 2006-10-10
EP1706097A2 (de) 2006-10-04
CA2552909A1 (en) 2005-07-21
ZA200605611B (en) 2007-11-28
NZ548422A (en) 2010-04-30
AU2005203884B2 (en) 2011-04-14
WO2005065713A2 (de) 2005-07-21
AU2005203884A1 (en) 2005-07-21
DE102004001558A1 (de) 2005-08-18
US20080255125A1 (en) 2008-10-16
CA2552909C (en) 2014-05-27
WO2005065713A3 (de) 2006-05-11

Similar Documents

Publication Publication Date Title
BR112018005110A2 (pt) Composição emoliente e sua utilização cosmética, composição cosmética, dermatológica ou farmacêutica e sua utilização cosmética e processo de tratamento cosmético da pele
BRPI0919316A2 (pt) sistema comestico ou dermatologico, e, metodo para tratar cosmeticamente pele ou cabelo
BRPI0913983A2 (pt) composição cosmética e/ou terapêutica, e, método para fabricar um produto para cuidado da pele tópico
CY1111177T1 (el) Ενωση φαινοθειαζινιου για επουλωση τραυματων
BRPI0506305A (pt) artigos e métodos de tratamento da pele
WO2005102252A3 (de) Haut- und/oder haarmittel enthaltend verbindungen mit isoprenoider struktur
BRPI0816214B8 (pt) uso cosmético, composição cosmética e/ou dermatológica, e, métodos para o tratamento cosmético da pele, para o tratamento cosmético de sinais cutâneos de envelhecimento e/ou fotoenvelhecimento e para o tratamento cosmético para prevenir e/ou tratar substâncias queratinosas secas
BRPI0700678A (pt) método para aperfeiçoar comportamentos de sono
ATE200419T1 (de) Haut- und/oder haardepigmentierungsmittel
BRPI0811534A2 (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, método para tratar câncer em um animal de sangue quente, composição farmacêutica, e, processo para preparar um composto ou um sal farmaceuticametne aceitável do mesmo.
BRPI1009860A2 (pt) composto, uso do mesmo, composição farmacêutica e método para tratamento terapêutico ou prevenção de doenças em humanos ou animais
EA200970154A1 (ru) Косметические или дерматологические препараты, содержащие n-ацетилцистеин
ATE513562T1 (de) Nicht-spezifische immunstimulierende mittel
BRPI0720500A8 (pt) Preparação líquida transdérmica
GT200500378A (es) Macrolidos
BR112014014973A2 (pt) preparações contendo emodepside amorfo
BRPI0506888A (pt) composições de suplemento lìquido compreendendo um ou mais medicamentos
BRPI0518855A2 (pt) medicamento para aplicaÇço higiÊnica no ouvido
WO2007113531A8 (en) Topical drug delivery
WO2008042557A3 (en) Formulation and method for a shampoo for animals
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
BR112018013105A2 (pt) composições e métodos para reduzir a irritação da pele
BRPI0611526A2 (pt) composição tópica contendo gelatina
FR2913602B1 (fr) Composition cosmetique et dermocosmetique ou pharmaceutique destinee au soin de peaux agressees par des traitements esthetiques,cosmetiques ou therapeutiques tels que interventions chirurgicales,traitements lasers,dermabrasions
MX2007011486A (es) Formulaciones topicas de antibioticos de acido borinico y sus metodos de uso.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BAYER ANIMAL HEALTH GMBH (DE)

Free format text: TRANSFERIDO DE: BAYER HEALTHCARE AG

B25A Requested transfer of rights approved

Owner name: BAYER INTELLECTUAL PROPERTY GMBH (DE)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]